معرفی
Prof. Martin Jinek is a Full Professor of Biochemistry at the University of Zurich (UZH), leading the Jinek Group. He joined UZH in 2013 as an Assistant Professor and was promoted to Full Professor in 2024. His research focuses on molecular mechanisms of protein-RNA interactions, CRISPR-Cas systems, and gene editing. He holds a PhD from the European Molecular Biology Laboratory (EMBL) and completed postdoctoral research at UC Berkeley with Jennifer Doudna.
- Education:
- B.A. in Natural Sciences (Trinity College, Cambridge, UK)
- M.Sc. in Chemistry (University of Cambridge, UK)
- PhD in Biochemistry (EMBL, Heidelberg, Germany)
- Awards:
- EMBO Member (2024)
- Howard Hughes Medical Institute International Research Scholar (2017)
- Georg Friedrich Götz Award (2016)
His lab investigates structural and biochemical mechanisms of CRISPR-Cas systems, with applications in genome editing and microbial defense. Notable contributions include foundational work on Cas9 and Cas12a mechanisms, published in high-impact journals like Nature and Cell.
Grants and funding include ERC Starting Grant (2013) and HHMI support. He collaborates internationally on projects like engineered probiotics for gut health and CRISPR-based therapies.
Labs/Teams: Jinek Group at UZH’s Department of Biochemistry, specializing in structural biology and CRISPR innovation.
